Dr. Raymond A. Huml is the Vice President of Rare & Orphan Disease Strategy at Sciensus, with over 30 years in the healthcare and biopharmaceutical industries. A leader in rare disease research and global due diligence, he has driven nearly $3 billion in capital commitments. A prolific author and award-winning expert, he is dedicated to advancing rare disease innovation, diversity, and global healthcare, including his Peace Corps service in Ghana.
- With over 30 years in the healthcare and biopharmaceutical industries
- Has driven nearly $3 billion in capital commitments
- Prolific author and award-winning expert
Willem Korevaar is Strategic Customer Manager at Adven, responsible for Energy as a Service projects in the Food & Beverage sector. Willem has a background in process engineering and extensive knowledge of beverage industry. He holds a master’s degree in public administration.
Mining Engineer with a master in Energy and Fuels from Universidad Politécnica of Madrid
Energy Risk Professional certificate from Global Association of Risk Professionals (GARP)
11 years professional experience in energy markets (Energy Management, Trading and Origination). The last 3 years working as originator at Statkraft
Jonathan holds a PhD from University College Cork entitled Molecular Interactions in Solutions and Gels of Galactomannans and Carrageenans. Jonathan is currently the Business Development Director for Functional Technologies at Kerry Europe, which include Enzymes, and Brewing Ingredients. He began his career at Kerry in 2007 as part of the R&D team developing new product innovations and now spends his time working with customers to provide solutions that help address current market needs and improve process efficiency while maintaining product quality and consistency.
As leader of the Pitcher Customer Success team, Dirk Abeel applies his broad and deep expertise in sales enablement, commercial excellence, and omnichannel transformation to help our customers successfully execute their commercial strategies on the Pitcher platform
At MED Institute, Samantha leads and supports clinical projects and strategies. She has over 30 years of experience in the medical field, including clinical research, medical education, regulatory affairs, sterile processing, materials management, and surgical technology. She is certified as a Surgical Technologist, Surgical First Assistant, and Clinical Research Professional. She holds a BS in Career and Technical Education from Indiana State University, an AAS in Surgical Technology from Ivy Tech Community College, and is currently pursuing an MPH degree from Purdue Global University.
As an executive in R&D, Technology, Innovation, Product Development and Engineering, I specialize in leading high-impact teams, driving breakthrough product innovation, and transforming cutting-edge research into commercially successful solutions.
With 20+ years of experience, I have scaled multi-million-dollar R&D operations, launched AI-powered products, and led cross-functional teams of engineers, IT, data scientists, and clinicians to bring transformative technologies to market.
Executive Expertise & Leadership Impact:
– AI & Data Strategy – Driving AI, real-world data (RWD), and digital innovations to enhance clinical outcomes.
– R&D Leadership & Innovation – Led end-to-end development of Class II & III medical devices, in-vitro diagnostics, digital health, digital therapeutics, and drug-device combination products.
– Regulatory & Market Access – Deep expertise in FDA, MDR, ISO 13485, ensuring faster product approvals & go-to-market execution.
– Product Commercialization – Managed $3B+ product portfolios, driving market adoption & revenue growth.
– Strategic Partnerships & GTM Strategy – Spearheading alliances with biopharma, payers, and AI-driven startups.
– Led World Wide Product & Technology Planning that aligned with corporate strategy and goals, by involving cross-
Dr. Hatice Bilgic Lim is a leader in medical device clinical development and regulatory writing with over 25 years of experience in research, strategy, and communication. She has held senior positions at leading MedTech companies, including Medtronic, Becton Dickinson, and Philips, where she led cross-functional teams in creating high-impact clinical and regulatory strategies that facilitated global product approvals. Her expertise lies in developing and executing effective clinical trials for innovative technologies that enhance access to care across diverse global markets.
In addition to her industry experience, Dr. Bilgic Lim has a background in academia and nonprofit leadership, emphasizing the advancement of healthcare through research, communication, and training. She is the founder of Academy HBL, where she mentors students and professionals in scientific communication and career development, and she serves as a board member for various academic nonprofits.
At the OCT Medical Devices USA 2025 conference, Dr. Bilgic Lim will lead a roundtable discussion titled “Strategic Leadership in MedTech Clinical Development: Creating Agile, High-Impact Trial Strategies.” This session will draw on her hands-on experience in designing streamlined, globally aligned clinical programs that not only meet regulatory milestones but also accelerate innovation.
